German biosimilar manufacturer STADA Arzneimittel reported a 9% revenue increase in the first half of 2024, with over €2 ...

Genpact Ltd. (G), an IT company, and Stada Arzneimittel AG (STDAY.PK, STDAF.PK), a maker of consumer healthcare, generic, and ...

Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, and STADA (SAZ.DE), a leading manufacturer of consumer healthcare, generic and specialty ...

Buyout firm GTCR is in advanced talks on a potential acquisition of German generic drugmaker Stada Arzneimittel AG, people ...

Chicago-based buyout firm GTCR is in advanced talks on a potential acquisition of German generic drugmaker Stada Arzneimittel ...

Taking a closer look at the numbers, Stada’s specialty pharma arm grew sales 14% to 417.3 million euros ($464 million) during the first half of 2024. Stada credited the specialty pharma growth ...

German generics major STADA Arzneimittel (SAZ: Xetra) today announced that it achieved sales of more than 2 billion euros ($2.23 billion) in the first half of 2024. Group revenues in the six months ...

STADA, the German healthcare company that focuses on generics and specialty pharma, has acquired LEO Pharma and the existing FITO trademark in the GCC, North Africa, the Middle East and selected Asian ...